Jeffrey Givand, PhD Merck & Co., Inc.
Jeffrey Givand, PhD Merck & Co., Inc. Executive Director, Device and Combination Product Development
Jeff Givand is currently leading the Device Development R&D team within Merck as Executive Director. Jeff’s team leads the concepting, design, development and commercialization efforts for device and combination products in support of small molecule, biologics and vaccine products in development at Merck. Device technologies within his team’s scope include inhalers, injectors, implantation and associated drug delivery devices. He has over 23 years of experience at Merck in areas ranging from solid oral dosage formulation and process development, Quality by Design and process analytical technology implementation within pharmaceutical drug product processes, sterile primary container characterization, and device/combination product development.